These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 23233283)

  • 1. Effects of submicron particles on formation of micron-sized particles during long-term storage of an interferon-β-1a solution.
    Bai S; Murugesan Y; Vlasic M; Karpes LB; Brader ML
    J Pharm Sci; 2013 Feb; 102(2):347-51. PubMed ID: 23233283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of submicron (0.1-1 μm) particles in therapeutic proteins by nanoparticle tracking analysis.
    Vasudev R; Mathew S; Afonina N
    J Pharm Sci; 2015 May; 104(5):1622-31. PubMed ID: 25737284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Impact of Inadequate Temperature Storage Conditions on Aggregate and Particle Formation in Drugs Containing Tumor Necrosis Factor-Alpha Inhibitors.
    Vlieland ND; Nejadnik MR; Gardarsdottir H; Romeijn S; Sediq AS; Bouvy ML; Egberts ACG; van den Bemt BJF; Jiskoot W
    Pharm Res; 2018 Feb; 35(2):42. PubMed ID: 29404710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interference from Proteins and Surfactants on Particle Size Distributions Measured by Nanoparticle Tracking Analysis (NTA).
    Bai K; Barnett GV; Kar SR; Das TK
    Pharm Res; 2017 Apr; 34(4):800-808. PubMed ID: 28155075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization and quantitation of aggregates and particles in interferon-β products: potential links between product quality attributes and immunogenicity.
    Barnard JG; Babcock K; Carpenter JF
    J Pharm Sci; 2013 Mar; 102(3):915-28. PubMed ID: 23233295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Comprehensive Evaluation of Nanoparticle Tracking Analysis (NanoSight) for Characterization of Proteinaceous Submicron Particles.
    Tian X; Nejadnik MR; Baunsgaard D; Henriksen A; Rischel C; Jiskoot W
    J Pharm Sci; 2016 Nov; 105(11):3366-3375. PubMed ID: 27663383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Incremental Siliconization Levels on Soluble Aggregates, Submicron and Subvisible Particles in a Prefilled Syringe Product.
    Bai S; Landsman P; Spencer A; DeCollibus D; Vega F; Temel DB; Houde D; Henderson O; Brader ML
    J Pharm Sci; 2016 Jan; 105(1):50-63. PubMed ID: 26852839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compatibility, physical stability, and characterization of an IgG4 monoclonal antibody after dilution into different intravenous administration bags.
    Kumru OS; Liu J; Ji JA; Cheng W; Wang YJ; Wang T; Joshi SB; Middaugh CR; Volkin DB
    J Pharm Sci; 2012 Oct; 101(10):3636-50. PubMed ID: 22733600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of Nanoparticle Tracking Analysis for Quantification and Sizing of Submicron Particles of Therapeutic Proteins.
    Zhou C; Krueger AB; Barnard JG; Qi W; Carpenter JF
    J Pharm Sci; 2015 Aug; 104(8):2441-50. PubMed ID: 26017684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Practical Considerations for Detection and Characterization of Sub-Micron Particles in Protein Solutions by Nanoparticle Tracking Analysis.
    Gruia F; Parupudi A; Polozova A
    PDA J Pharm Sci Technol; 2015; 69(3):427-39. PubMed ID: 26048748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Multicompany Assessment of Submicron Particle Levels by NTA and RMM in a Wide Range of Late-Phase Clinical and Commercial Biotechnology-Derived Protein Products.
    Hubert M; Yang DT; Kwok SC; Rios A; Das TK; Patel A; Wuchner K; Antochshuk V; Junge F; Bou-Assaf GM; Cao S; Saggu M; Montrond L; Afonina N; Kolhe P; Loladze V; Narhi L
    J Pharm Sci; 2020 Jan; 109(1):830-844. PubMed ID: 31647951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoparticle tracking analysis of particle size and concentration detection in suspensions of polymer and protein samples: Influence of experimental and data evaluation parameters.
    Gross J; Sayle S; Karow AR; Bakowsky U; Garidel P
    Eur J Pharm Biopharm; 2016 Jul; 104():30-41. PubMed ID: 27108267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solution behavior of IFN-beta-1a: an empirical phase diagram based approach.
    Fan H; Ralston J; Dibiase M; Faulkner E; Middaugh CR
    J Pharm Sci; 2005 Sep; 94(9):1893-911. PubMed ID: 16052555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of different analytical methods for the characterization of non-spherical micro- and nanoparticles.
    Mathaes R; Winter G; Engert J; Besheer A
    Int J Pharm; 2013 Sep; 453(2):620-9. PubMed ID: 23727141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preanalytical, analytical, and biological variation of blood plasma submicron particle levels measured with nanoparticle tracking analysis and tunable resistive pulse sensing.
    Mørk M; Pedersen S; Botha J; Lund SM; Kristensen SR
    Scand J Clin Lab Invest; 2016 Sep; 76(5):349-60. PubMed ID: 27195974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection and Sizing of Submicron Particles in Biologics With Interferometric Scattering Microscopy.
    Wong NA; Uchida NV; Dissanayake TU; Patel M; Iqbal M; Woehl TJ
    J Pharm Sci; 2020 Jan; 109(1):881-890. PubMed ID: 31160046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity of recombinant human interferon beta interacting with particles of glass, metal, and polystyrene.
    Van Beers MM; Gilli F; Schellekens H; Randolph TW; Jiskoot W
    J Pharm Sci; 2012 Jan; 101(1):187-99. PubMed ID: 21918983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shape and size of virgin ultrahigh molecular weight GUR 4150 HP polyethylene powder.
    Pienkowski D; Hoglin DP; Jacob RJ; Saum KA; Nicholls PJ; Kaufer H
    J Biomed Mater Res; 1996; 33(2):65-71. PubMed ID: 8736024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Submicron Protein Particle Characterization using Resistive Pulse Sensing and Conventional Light Scattering Based Approaches.
    Barnett GV; Perhacs JM; Das TK; Kar SR
    Pharm Res; 2018 Feb; 35(3):58. PubMed ID: 29423663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterisation of Stress-Induced Aggregate Size Distributions and Morphological Changes of a Bi-Specific Antibody Using Orthogonal Techniques.
    Hamrang Z; Hussain M; Tingey K; Tracka M; Casas-Finet JR; Uddin S; van der Walle CF; Pluen A
    J Pharm Sci; 2015 Aug; 104(8):2473-81. PubMed ID: 26053418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.